GSDME has also been reported to play a role in chimeric antigen receptor (CAR) T cell therapy in cancer patients: Granzyme B released by CAR-T cells activated caspase 3 and induced GSDME-mediated pyroptosis in macrophages, triggering a serious complication known as cytokine release syndrome97. Here, CASP3 is linked to cancer.